Addition of Rapamycin to Anti-CD3 Antibody Improves Long-Term Glycaemia Control in Diabetic NOD Mice

Open Access

Peer-reviewed

Research Article

Shira Perl ,

* E-mail: perls@nhlbi.nih.gov

Affiliations Center for Human Immunology, NHLBI, NIH, Bethesda, Maryland, United States of America, Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯
Jordan Perlman,

Affiliation Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯
R. P. Weitzel,

Affiliation Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯
Oswald Phang,

Affiliation Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯
Matthew M. Hsieh,

Affiliation Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯
John Tisdale

Affiliation Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States of America
⨯

Reader Comments (0)

Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Intraperitoneal injections
Is the Subject Area "Intraperitoneal injections" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Glucose tolerance tests
Is the Subject Area "Glucose tolerance tests" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.
Glucose tolerance
Is the Subject Area "Glucose tolerance" applicable to this article?

Thanks for your feedback.
Hyperglycemia
Is the Subject Area "Hyperglycemia" applicable to this article?

Thanks for your feedback.